What started as a scientific research project at Wageningen University (The Netherlands) in 1999 paved the way for Dr. Tineke Creemers and Dr. Willem Jan Bosma to develop valuable new insights into the effects of honey on wound healing.
They found that the composition of the honey used – the presence of active enzymes and the honey’s acidity (low pH) – was, in fact, crucial to these effects. Honey from the supermarket, for example, does not have this optimal composition. Often, supermarket honey has been subjected to overheating, which is detrimental to the enzymes.
Bfactory was established in 2000 as an independent enterprise. In this start-up phase, the goal was to get our products registered as medical devices for human use, which requires clinical research and case studies. The strict requirements related to this classification clearly demonstrate the confidence that Tineke and Willem Jan have in the knowledge and products they have developed!
The first products for medical wound care for humans were introduced under the brand name Revamil® in 2004. This market continues to grow in both diversity of applications and in international distribution.
Vetramil® was then developed for veterinary use, and various adaptations were made to improve the product's ease-of-use for all kinds of large and small pets.
Due to the rapid growth of Bfactory, our small-scale production site in the Netherlands has all too quickly become unable to meet the demand. In our search to find the best circumstances and most professional beekeepers, the Bfactory honey is now collected from remote areas in Europe that have just the right flora. Pesticides are never used, and in order to ensure the ideal composition, the honey is collected at specific times.
Strict quality standards ensure that only the honey with the correct composition and without chemical residues is used for Bfactory products.
Our bee colonies are cared for in the traditional manner by professional beekeepers, with respect for nature and for the health of the bees.